Related Experiment Video
Updated: Aug 5, 2026
06:43
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
Research Progress on Regulating Neuroinflammation After Spinal Cord Injury by Targeting the cGAS-STING Pathway
Nanjian Xu1,2, Weihu Ma1,2, Weixin Dong1,2
1Spine Surgery Center, Ningbo No.6 Hospital, 1059# Zhongshan East Road, Ningbo City, 315040, Zhejiang Province, China.
Neuromolecular Medicine
|July 30, 2026
Summary
Spinal cord injury (SCI) triggers neuroinflammation via the cGAS-STING pathway, activating immune cells and hindering recovery. Targeting this pathway offers potential therapeutic strategies for SCI, but clinical translation faces challenges.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Neuroinflammation post-spinal cord injury (SCI) impedes functional recovery.
- Mitochondrial DNA (mtDNA) released after SCI activates the cGAS-STING pathway.
- This activation promotes a pro-inflammatory phenotype in microglia and macrophages.
Purpose of the Study:
- To review the role of the cGAS-STING pathway in SCI-induced neuroinflammation.
- To explore intervention strategies targeting the cGAS-STING pathway for SCI.
- To identify challenges in the clinical translation of these strategies.
Main Methods:
- Literature review of studies on the cGAS-STING pathway in SCI.
- Analysis of signaling networks including TLR, ROS, NLRP3 inflammasome, and autophagy.
- Examination of therapeutic approaches like small molecules, genetic interventions, and nanomaterials.
Main Results:
- The cGAS-STING pathway interacts with TLR, ROS, NLRP3 inflammasome, and autophagy, influencing microglial and macrophage activation.
- This pathway can enhance pyroptosis through Caspase-1 and Gasdermin D activation.
- Emerging strategies aim for precise immunomodulation in the neuroimmune microenvironment.
Conclusions:
- The cGAS-STING pathway is a critical regulator of neuroinflammation after SCI.
- Targeting this pathway presents therapeutic potential but requires overcoming delivery and specificity challenges.
- Further research is needed to advance clinical translation of cGAS-STING-based therapies for SCI.